Interestingly, GPR124 is also a potential target for blood–brain barrier devastation in stroke and glioblastoma,8 but whether the BSCB disruption is related to GPR124 and whether it can rescue SCI remains unknown. This evidence concerns the gene ADGRA2 and glioblastoma.